USAspending.gov records show Leidos Biomedical Research Inc.'s non-competed NIH contract to run the Frederick National Laboratory for Cancer Research has obligated a cumulative $4.81 billion since 2008. The lab's operation is also the subject of a still-unresolved recompete fight.